Efficacy and safety of tadalafil 5 mg once daily in Asian males with lower urinary tract symptoms secondary to benign prostatic hyperplasia (BPH-LUTS): Integrated analysis from 3 Asian double-blind, randomized, placebo-controlled clinical studies

Abstract Category

Male Lower Urinary Tract Symptoms (LUTS) / Voiding Dysfunction

Links
	Abstract 660
	Overview of Benign Prostatic Obstruction Scientific Podium Poster Session 42
	Thursday 23rd October 2014
	15:50 - 15:55
	Room 1
	Benign Prostatic Hyperplasia (BPH) Bladder Outlet Obstruction Clinical Trial Male Voiding Dysfunction
	1. 1. Department of Urology, Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi, Chuo, Japan, 2. 2. Lilly Research Laboratories Japan, Medical Science, Eli Lilly Japan K.K., Kobe, Japan, 3. 3. Lilly Research Laboratories Japan, Statistical Science, Eli Lilly Japan K.K., Kobe, Japan, 4. 4. Lilly Research Laboratories, Eli Lilly and Co., Indianapolis, Indiana, USA
Presenter
M Masayuki Takeda
Abstract PDF Edit Abstract Abstract Centre